RIVAROXABAN (Xarelto®)

Clinical Indication

Treatment of VTE in paediatric patients

Date of classification

February 2022

Yellow

Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .